According to a new report, published by KBV research, The Global IV Dressing Market size is expected to reach $1.3 billion by 2031, rising at a market growth of 5.9% CAGR during the forecast period. In the year 2023, the market attained a volume of 44,950.9 thousand units, experiencing a growth of 17.3% (2020-2023).
Central line-associated bloodstream infections (CLABSIs) and CRBSIs are serious and potentially life-threatening infections associated with the use of central venous catheters and other intravascular devices. Properly applied IV dressings prevent these infections by creating a barrier that lowers the risk of microbial contamination at the catheter insertion site. For instance, the Australian Institute of Health and Welfare reports that hospitalizations increased 6.3% between 2020 and 2021. As hospitals strive to reduce the incidence of healthcare-associated infections, the demand for IV dressings with antimicrobial properties and advanced barrier technologies increases.
The Transparent segment is leading the Global IV Dressing Market by Type in 2023; thereby, achieving a market value of $944.6 Million by 2031. Transparent IV dressings provide healthcare providers with a clear view of the insertion site without the need to remove the dressing. This visibility allows for continuous monitoring of the catheter insertion site, enabling early detection of complications such as infiltration, phlebitis, or signs of infection. Transparent IV dressings make it easy for healthcare providers to inspect the insertion site during routine assessments or when administering medications or fluids. The clear film allows for visual inspection without removing the dressing, saving time, and reducing the risk of contamination or trauma to the site.
The Hospitals segment is growing at a CAGR of 5.3 % during the forecast period. Chronic diseases often require ongoing medical management and may lead to complications that necessitate hospitalization. Patients with conditions like cancer, chronic kidney diseases, and autoimmune disorders frequently require intravenous therapy during hospital stays for treatments such as chemotherapy, dialysis, and immunosuppressive therapy. The increasing hospital admissions of these patients drive the demand for IV dressings to secure intravenous access and facilitate the safe administration of medications and fluids.
Full Report: https://www.kbvresearch.com/iv-dressing-market/
The North America region dominated the Global IV Dressing Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a region value of $502.6 Million by 2031. The Europe region poised to grow at a CAGR of 5.5% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 6.7% during (2024 - 2031).
By Type (Volume, Thousand Units, USD Billion, 2020-2031)
By End-use (Volume, Thousand Units, USD Billion, 2020-2031)
By Geography (Volume, Thousand Units, USD Billion, 2020-2031)
Unique Offerings 
